These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1825568)
21. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets. Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845 [TBL] [Abstract][Full Text] [Related]
22. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910 [TBL] [Abstract][Full Text] [Related]
23. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor. Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557 [No Abstract] [Full Text] [Related]
24. Modulation by adenosine of thromboxane A2 receptor-mediated constriction in the human umbilical artery. Di Grande A; Malatino LS; Boura AL; Read MA; Walters WA Int J Clin Pharmacol Ther; 1994 Jul; 32(7):344-6. PubMed ID: 7952795 [TBL] [Abstract][Full Text] [Related]
25. Pronounced effects of the combination of a new thromboxane antagonist (GR32191) and heparin on bleeding time in man. de Boer A; Kroon JM; Kroon C; van Vliet A; Schoemaker HC; Breimer DD; Donoghue S; Cohen AF Thromb Haemost; 1992 Jul; 68(1):24-9. PubMed ID: 1514168 [TBL] [Abstract][Full Text] [Related]
26. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481 [TBL] [Abstract][Full Text] [Related]
27. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. Swann PG; Venton DL; Le Breton GC FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230 [TBL] [Abstract][Full Text] [Related]
28. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man. Gresele P; Deckmyn H; Arnout J; Lemmens J; Janssens W; Vermylen J Lancet; 1984 May; 1(8384):991-4. PubMed ID: 6143969 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the pharmacokinetics and pharmacodynamics of a new oral thromboxane A2-receptor antagonist AA-2414 in normal subjects: population analysis. Hussein Z; Samara E; Locke CS; Orchard MA; Ringham GL; Granneman GR Clin Pharmacol Ther; 1994 Apr; 55(4):441-50. PubMed ID: 8162671 [TBL] [Abstract][Full Text] [Related]
30. Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191. Armstrong RA; Humphrey PP; Lumley P Br J Pharmacol; 1993 Oct; 110(2):548-52. PubMed ID: 8242229 [TBL] [Abstract][Full Text] [Related]
31. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction. Molimard M; Martin CA; Naline E; Hirsch A; Advenier C Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124 [TBL] [Abstract][Full Text] [Related]
32. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets. Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979 [TBL] [Abstract][Full Text] [Related]
33. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen. Wagner WR; Hubbell JA J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345 [TBL] [Abstract][Full Text] [Related]
34. Effect of GR32191 and other thromboxane receptor blocking drugs on human platelet deposition onto de-endothelialized arteries. Foster MR; Hornby EJ; Stratton LE Thromb Res; 1992 Mar; 65(6):769-84. PubMed ID: 1386166 [TBL] [Abstract][Full Text] [Related]
35. Effect of the specific thromboxane receptor blocking drug AH23848 in patients with angina pectoris. De Bono DP; Lumley P; Been M; Keery R; Ince SE; Woodings DF Br Heart J; 1986 Dec; 56(6):509-17. PubMed ID: 2948534 [TBL] [Abstract][Full Text] [Related]
36. GR32191 and the role of thromboxane A2 in asthma--preclinical and clinical findings. Coleman RA Agents Actions Suppl; 1991; 34():211-20. PubMed ID: 1793065 [TBL] [Abstract][Full Text] [Related]
37. Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide. Kemp BK; McPherson GA Eur J Pharmacol; 1998 Aug; 354(2-3):173-8. PubMed ID: 9754918 [TBL] [Abstract][Full Text] [Related]